Patrick C. Roche, SVP Research & Development at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 3,491 shares at $2.69 ($9K) on 2016-03-09, disclosed to the SEC on 2016-03-09.
Scheduled sale ($9k) by SVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |